The Alluminox™ platform is an investigational platform based on a cancer therapy called photoimmunotherapy, which was developed by Dr. Hisataka Kobayashi and team from the National Cancer Institute in the United States. Rakuten Medical is currently developing the Alluminox™ platform as a technology consisting of an investigational drug, device and other related components.